首页> 美国卫生研究院文献>Biochemical Journal >Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation
【2h】

Another biological effect of tosylphenylalanylchloromethane (TPCK): it prevents p47phox phosphorylation and translocation upon neutrophil stimulation

机译:甲苯磺酰苯丙氨酰氯(TPCK)的另一种生物效应:它可防止中性粒细胞刺激后p47phox磷酸化和移位

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

TPCK (tosylphenylalanylchloromethane), first discovered as a serine protease inhibitor, has been described to affect in diverse systems a number of physiological events probably unrelated to its antiprotease effect, such as proliferation, apoptosis and tumour formation. In the present study, we focus on its inhibition of the neutrophil respiratory burst, an important element of non-specific immunological defence. The superoxide anion-producing enzyme, NADPH oxidase, is quiescent in resting cells. Upon cell stimulation, the redox component, membrane-bound flavocytochrome b558, is activated when the cytosolic factors (p47phox, p67phox and p40phox, as well as the small GTPase Rac) associate with it after translocating to the membrane. This requires the phosphorylation of several p47phox serine residues. The signal transduction events leading to enzyme activation are not completely understood. In the past, the use of diverse protease inhibitors suggested that proteases were involved in NADPH oxidase activation. We suggested previously that TPCK could prevent enzyme activation by the phorbol ester PMA, not due to inhibition of a protease, but possibly to inhibition of the cytosolic factor translocation [Chollet-Przednowed and Lederer (1993) Eur. J. Biochem. >218, 83–93]. In the present work, we show that TPCK, when added to cells before PMA, prevents p47phox phosphorylation and hence its translocation; moreover, when PMA-stimulated cells are incubated with TPCK, p47phox is dephosphorylated and dissociates from the membrane. These results are in line with previous suggestions that the respiratory burst is the result of a series of continuous phosphorylation and dephosphorylation events. They suggest that TPCK leads indirectly to activation of a phosphatase or inactivation of a kinase, and provide the first clue towards understanding the steps leading to its inhibition of NADPH oxidase activation.
机译:TPCK(甲苯磺酰基苯丙氨酰氯甲烷),首先被发现是一种丝氨酸蛋白酶抑制剂,据描述会影响多种系统的许多生理事件,这些生理事件可能与其抗蛋白酶作用无关,例如增殖,凋亡和肿瘤形成。在本研究中,我们专注于其对嗜中性粒细胞呼吸爆发的抑制作用,这是非特异性免疫防御的重要组成部分。产生超氧阴离子的酶NADPH氧化酶在静止细胞中处于静止状态。在细胞刺激后,当胞质因子(p47 phox ,p67 phox 和p40 phox )被激活时,膜结合的黄细胞色素b558被氧化还原成分激活。 ,以及小的GTPase Rac)在转运到膜后与其结合。这需要几个p47 phox 丝氨酸残基的磷酸化。导致酶激活的信号转导事件尚未完全了解。过去,使用多种蛋白酶抑制剂提示蛋白酶参与了NADPH氧化酶的活化。我们以前曾提出TPCK可以阻止佛波酯PMA激活酶,这不是由于抑制蛋白酶,而是由于抑制了胞质因子的转运[Chollet-Przednowed and Lederer(1993)Eur。Chem.Lett。,2002,5,1877。 J.生物化学。 > 218 ,83-93]。在目前的工作中,我们表明TPCK在PMA之前添加到细胞中时,可防止p47 phox 磷酸化,从而防止其移位。此外,当PMA刺激的细胞与TPCK孵育时,p47 phox 会被去磷酸化并从膜上解离。这些结果与先前的建议一致,即呼吸爆发是一系列连续的磷酸化和去磷酸化事件的结果。他们认为TPCK间接导致磷酸酶的激活或激酶的失活,并为理解导致其抑制NADPH氧化酶激活的步骤提供了第一个线索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号